EUVIMEDEUVIMED entdecken
Crossref

Clinical characteristics and outcomes of atrial flutter in neonates

Geena Kim iD, Ji Hye Shin, Mi Hyeon Gang, Yong Wook Lee, Mea-Young Chang, Hawon Jang, Hong Ryang Kil

Pediatrics International · 2023

DOI: 10.1111/ped.15714 ↗

Kurz gefasst

Fachartikel in der Zeitschrift Pediatrics International, 2023. Verfasst von Geena Kim und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Chungnam National University Sejong Hospital, Chungnam National University School of Medicine, Sejong, Republic of Korea. Hauptthemen laut MEDLINE: Atrial Flutter, Heart Failure. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 17 Literaturangaben. Gefördert von: Chungnam National University Hospital Research Fund, 2016.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Background

Atrial flutter is an uncommon arrhythmia that can cause severe morbidity, including heart failure and even death in refractory cases. This study investigated the clinical characteristics, treatment, and long‐term outcomes of patients with neonatal atrial flutter and its association with heart failure.

Methods

We retrospectively reviewed atrial flutter cases observed in our center between 1999 and 2021 and analyzed the clinical characteristics, treatment, and recurrence according to the presence of heart failure.

Results

The study comprised 15 patients with atrial flutter, with median bodyweight and gestational age of 2.7 kg, 37 +4 weeks, respectively. Twelve patients were diagnosed with atrial flutter on the first day of life. The median atrial and ventricular rates were 440/min, 220/min, respectively. Four patients exhibited congestive heart failure. Episodic recurrence was noted in five patients and occurred at a higher rate in patients with congestive heart failure ( p = 0.004). Antiarrhythmic drugs for maintenance treatment were administered more often in patients with heart failure ( p = 0.011). Initial treatment included direct current cardioversion ( n = 9), digoxin ( n = 4), and observation ( n = 2). Four patients treated with cardioversion experienced recurrence during the neonatal period, and none of those treated with digoxin experienced recurrence. The median follow‐up duration was 7 years, during which no atrial flutter recurrence was evident.

Conclusion

Neonates with congestive heart failure had a higher recurrence of atrial flutter. Direct current cardioversion is the most reliable treatment for neonatal atrial flutter, whereas digoxin may be a viable treatment option in refractory and recurrent cases.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Atrial FlutterHeart FailureInfant, NewbornHumansRetrospective StudiesDigoxinAnti-Arrhythmia Agents

Stichwörter der Autor:innen

atrial fluttercardioversioncongestive heart failuredigoxinneonate

Substanzen

DigoxinAnti-Arrhythmia Agents

Autor:innen und Institutionen

  • Department of Pediatrics, Chungnam National University Sejong Hospital, Chungnam National University School of Medicine, Sejong, Republic of Korea.
  • Department of Pediatrics, Chungnam National University Hospital, Chungnam National University School of Medicine, Daejeon, Republic of Korea.

ORCID-Profile: Geena Kim

Förderung

  • Chungnam National University Hospital Research Fund, 2016

Zitieren

APA

Kim, G., Shin, J. H., Gang, M. H., Lee, Y. W., Chang, M. Y., Jang, H., & Kil, H. R. (2023). Clinical characteristics and outcomes of atrial flutter in neonates. Pediatrics International. https://doi.org/10.1111/ped.15714

Vancouver

Kim G, Shin JH, Gang MH, Lee YW, Chang MY, Jang H, et al. Clinical characteristics and outcomes of atrial flutter in neonates. Pediatrics International. 2023. doi:10.1111/ped.15714

BibTeX
@article{Kim2023,
  author = {Kim, Geena and Shin, Ji Hye and Gang, Mi Hyeon and Lee, Yong Wook and Chang, Mea-Young and Jang, Hawon and Kil, Hong Ryang},
  title = {Clinical characteristics and outcomes of atrial flutter in neonates},
  journal = {Pediatrics International},
  year = {2023},
  doi = {10.1111/ped.15714}
}
Kostenlos starten →